Middle East Healthcare Co.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SA141H01UKH9
SAR
33.04
-24.46 (-42.54%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
768.97
791.13
733.74
748.88
732.07
712.66
689.21
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
768.97
791.13
733.74
748.88
732.07
712.66
689.21
Raw Material Cost
488.26
486.21
452.99
469.75
441.90
436.45
431.39
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
48.00
49.45
53.26
46.83
46.63
62.17
66.17
Selling and Distribution Expenses
193.27
193.58
179.20
177.44
174.29
170.48
140.18
Other Expenses
-4.80
-4.95
-5.33
-4.68
-4.66
-6.22
-6.62
Total Expenditure (Excl Depreciation)
681.53
679.79
632.19
647.19
616.19
606.93
571.57
Operating Profit (PBDIT) excl Other Income
87.4
111.30000000000001
101.5
101.7
115.9
105.7
117.6
Other Income
8.49
7.32
119.43
54.29
5.67
23.86
7.73
Operating Profit (PBDIT)
158.74
179.67
278.83
213.85
175.82
182.85
176.70
Interest
48.00
49.45
53.26
46.83
46.63
62.17
66.17
Exceptional Items
6.04
2.73
0.46
0.00
2.09
0.00
0.00
Gross Profit (PBDT)
280.71
304.92
280.75
279.13
290.17
276.21
257.82
Depreciation
62.81
61.01
57.85
57.88
54.27
53.27
51.33
Profit Before Tax
53.97
71.94
168.17
109.15
77.02
67.42
59.19
Tax
8.75
5.33
5.27
0.81
10.98
7.26
7.22
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
40.29
63.67
160.13
107.14
63.84
61.17
51.94
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
40.29
63.67
160.13
107.14
63.84
61.17
51.94
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.83
2.65
2.57
0.68
2.19
-1.02
0.03
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
43.12
66.31
162.71
107.82
66.03
60.15
51.97
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
1,843.15
1,803.59
1,786.20
1,626.11
1,699.33
1,636.63
1,572.12
Earnings per share (EPS)
0.44
0.69
1.74
1.16
0.69
0.66
0.56
Diluted Earnings per share
0.44
0.69
1.74
1.16
0.69
0.66
0.56
Operating Profit Margin (Excl OI)
11.37%
14.07%
13.84%
13.58%
15.83%
14.84%
17.07%
Gross Profit Margin
15.19%
16.81%
30.8%
22.3%
17.93%
16.93%
16.04%
PAT Margin
5.24%
8.05%
21.82%
14.31%
8.72%
8.58%
7.54%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 5.04% vs 9.11% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is -34.70% vs 21.77% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is -11.75% vs 9.59% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is 3.00% vs -15.27% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024

Compare Quarterly Results Of Middle East Healthcare Co. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SAR)
Change(%)
Net Sales
768.97
0
768.97
Other Operating Income
0.00
0.00
0.00
Total Operating income
768.97
0
768.97
Raw Material Cost
488.26
0
488.26
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
48.00
0
48.00
Selling and Distribution Expenses
193.27
0
193.27
Other Expenses
-4.80
0.00
-4.80
Total Expenditure (Excl Depreciation)
681.53
0
681.53
Operating Profit (PBDIT) excl Other Income
87.44
0.00
87.44
Other Income
8.49
0
8.49
Operating Profit (PBDIT)
158.74
0
158.74
Interest
48.00
0
48.00
Exceptional Items
6.04
0
6.04
Gross Profit (PBDT)
280.71
0
280.71
Depreciation
62.81
0
62.81
Profit Before Tax
53.97
0
53.97
Tax
8.75
0
8.75
Provisions and contingencies
0
0
0.00
Profit After Tax
40.29
0
40.29
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
40.29
0
40.29
Share in Profit of Associates
0
0
0.00
Minority Interest
2.83
0
2.83
Other related items
0.00
0.00
0.00
Consolidated Net Profit
43.12
0
43.12
Equity Capital
0
0
0.00
Face Value
10.00
0
0.00
Reserves
1,843.15
0
1,843.15
Earnings per share (EPS)
0.44
0
0.44
Diluted Earnings per share
0.44
0
0.44
Operating Profit Margin (Excl OI)
11.37%
0%
0.00
11.37%
Gross Profit Margin
15.19%
0%
0.00
15.19%
PAT Margin
5.24%
0%
0.00
5.24%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 76.90 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -2.79% vs 7.82% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 5.04% vs 9.11% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.31 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -34.99% vs -59.25% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -34.70% vs 21.77% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.02 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -12.83% vs 8.09% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -11.75% vs 9.59% in Sep 2024

Quarterly - Interest
Interest 4.80 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -3.03% vs -7.13% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 3.00% vs -15.27% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.37%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024